Provided by Tiger Trade Technology Pte. Ltd.

Phio Pharmaceuticals

1.04
+0.03002.97%
Volume:62.92K
Turnover:65.59K
Market Cap:12.08M
PE:-0.77
High:1.05
Open:1.03
Low:1.03
Close:1.01
52wk High:4.19
52wk Low:0.8127
Shares:11.62M
Float Shares:11.55M
Volume Ratio:0.60
T/O Rate:0.54%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3423
EPS(LYR):-1.4535
ROE:-113.71%
ROA:-65.77%
PB:0.96
PE(LYR):-0.72

Loading ...

Phio Pharmaceuticals to Meet Investors at H.C. Wainwright Global Investment Conference

Reuters
·
Yesterday

Phio Pharmaceuticals Price Target Maintained with a $14.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 26

Insider Move: Phio Pharmaceuticals Director Quietly Boosts His Stake

TIPRANKS
·
Aug 21

Phio Pharmaceuticals CEO Robert J. Bitterman Reports Purchase of $10,600 in Common Shares

Reuters
·
Aug 20

Phio Pharmaceuticals Announces Annual Shareholder Meeting

Reuters
·
Aug 15

Phio Pharma Wins U.S. Patent Allowance for BRD4-Targeting Intasyl Compound PH-894

Reuters
·
Aug 11

Phio Net Loss Widens to $4.14 Million in Q2 FY26

Reuters
·
Aug 07

Phio Pharmaceuticals Director Ronald Todd Plott Files Initial Beneficial Ownership Statement

Reuters
·
Jul 31

Phio Pharma Corrects Date for Renmark Virtual Non-deal Roadshow Presentation

Reuters
·
Jul 23

Phio Pharmaceuticals Names Dermatologist R. Todd Plott to Board

Reuters
·
Jul 21

Phio Pharma Wins US, Canada Patent Allowances for Intasyl Sirna Compounds

Reuters
·
Jul 15

Phio Pharmaceuticals to Present at Renmark Virtual Non-deal Roadshow

Reuters
·
Jun 26

Phio Pharma CEO Bitterman Joins Force Family Office Fireside Chat on Sirna Cancer Therapy

Reuters
·
Jun 25

Phio Pharmaceuticals to present at Life Sciences Investor Forum

Reuters
·
Jun 18

Phio Pharmaceuticals to present at Renmark virtual non-deal roadshow, host live Q&A

Reuters
·
May 26

Phio Pharmaceuticals to join Force Family Office fireside chat on skin cancer innovations

Reuters
·
May 12

Phio Pharma Q1 EPS $(0.34) Misses $(0.23) Estimate

Benzinga Earnings
·
May 08

Phio Pharmaceuticals Q1 FY26 net loss widens to $4 million; R&D expenses rise 215% to $2.8 million

Reuters
·
May 08

Phio Pharma to present at Renmark virtual non-deal roadshow, hosts live Q&A

Reuters
·
Apr 23

Phio Pharmaceuticals to join Force Family Office fireside chat on skin cancer program

Reuters
·
Apr 13